BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kachrimanidou M, Tsintarakis E. Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection. Microorganisms 2020;8:E200. [PMID: 32023967 DOI: 10.3390/microorganisms8020200] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Kiersnowska ZM, Lemiech-Mirowska E, Semczuk K, Michałkiewicz M, Sierocka A, Marczak M. Level of Knowledge of Medical Staff on the Basis of the Survey in Terms of Risk Management, Associated with Clostridioides difficile Infections. Int J Environ Res Public Health 2021;18:7060. [PMID: 34280996 DOI: 10.3390/ijerph18137060] [Reference Citation Analysis]
2 Zhou J, Horton JR, Yu D, Ren R, Blumenthal RM, Zhang X, Cheng X. Repurposing epigenetic inhibitors to target the Clostridioides difficile-specific DNA adenine methyltransferase and sporulation regulator CamA. Epigenetics 2021;:1-12. [PMID: 34523387 DOI: 10.1080/15592294.2021.1976910] [Reference Citation Analysis]
3 Shah T, Baloch Z, Shah Z, Cui X, Xia X. The Intestinal Microbiota: Impacts of Antibiotics Therapy, Colonization Resistance, and Diseases. Int J Mol Sci 2021;22:6597. [PMID: 34202945 DOI: 10.3390/ijms22126597] [Reference Citation Analysis]
4 Lindell AE, Zimmermann-kogadeeva M, Patil KR. Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota. Nat Rev Microbiol. [DOI: 10.1038/s41579-022-00681-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Navalkele BD, Polistico J, Sandhu A, Awali R, Krishna A, Chandramohan S, Tillotson G, Chopra T. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre. J Hosp Infect 2020;106:643-8. [PMID: 32991940 DOI: 10.1016/j.jhin.2020.09.027] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Phothichaisri W, Chankhamhaengdecha S, Janvilisri T, Nuadthaisong J, Phetruen T, Fagan RP, Chanarat S. Potential Role of the Host-Derived Cell-Wall Binding Domain of Endolysin CD16/50L as a Molecular Anchor in Preservation of Uninfected Clostridioides difficile for New Rounds of Phage Infection. Microbiol Spectr 2022;:e0236121. [PMID: 35377223 DOI: 10.1128/spectrum.02361-21] [Reference Citation Analysis]
7 Winichakoon P, Chaiwarith R, Chattipakorn N, Chattipakorn SC. Impact of gut microbiota on kidney transplantation. Transplant Rev (Orlando) 2021;36:100668. [PMID: 34688985 DOI: 10.1016/j.trre.2021.100668] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bian J, Liebert A, Bicknell B, Chen XM, Huang C, Pollock CA. Faecal Microbiota Transplantation and Chronic Kidney Disease. Nutrients 2022;14:2528. [PMID: 35745257 DOI: 10.3390/nu14122528] [Reference Citation Analysis]
9 Stolfi C, Maresca C, Monteleone G, Laudisi F. Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases. Biomedicines 2022;10:289. [DOI: 10.3390/biomedicines10020289] [Reference Citation Analysis]
10 Van den Abbeele P, Verstrepen L, Ghyselinck J, Albers R, Marzorati M, Mercenier A. A Novel Non-Digestible, Carrot-Derived Polysaccharide (cRG-I) Selectively Modulates the Human Gut Microbiota while Promoting Gut Barrier Integrity: An Integrated in Vitro Approach. Nutrients 2020;12:E1917. [PMID: 32610452 DOI: 10.3390/nu12071917] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
11 Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol 2021;116:1124-47. [PMID: 34003176 DOI: 10.14309/ajg.0000000000001278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Vakili B, Fateh A, Asadzadeh Aghdaei H, Sotoodehnejadnematalahi F, Siadat SD. Intestinal Microbiota in Elderly Inpatients with Clostridioides difficile Infection. Infect Drug Resist 2020;13:2723-31. [PMID: 32801806 DOI: 10.2147/IDR.S262019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
13 Grześkowiak ŁM. Editorial for the Special Issue: Clostridium difficile. Microorganisms 2021;9:368. [PMID: 33673344 DOI: 10.3390/microorganisms9020368] [Reference Citation Analysis]
14 Vasilescu I, Chifiriuc M, Pircalabioru GG, Filip R, Bolocan A, Lazăr V, Diţu L, Bleotu C. Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults. Front Microbiol 2022;12:651081. [DOI: 10.3389/fmicb.2021.651081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Tan R, Jin M, Shao Y, Yin J, Li H, Chen T, Shi D, Zhou S, Li J, Yang D. High-sugar, high-fat, and high-protein diets promote antibiotic resistance gene spreading in the mouse intestinal microbiota. Gut Microbes 2022;14:2022442. [PMID: 35030982 DOI: 10.1080/19490976.2021.2022442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhou J, Horton JR, Blumenthal RM, Zhang X, Cheng X. Clostridioides difficile specific DNA adenine methyltransferase CamA squeezes and flips adenine out of DNA helix. Nat Commun 2021;12:3436. [PMID: 34103525 DOI: 10.1038/s41467-021-23693-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Fishbein SR, Robinson JI, Hink T, Reske KA, Newcomer EP, Burnham CD, Henderson JP, Dubberke ER, Dantas G. Multi-omics investigation of Clostridioides difficile-colonized patients reveals pathogen and commensal correlates of C. difficile pathogenesis. Elife 2022;11:e72801. [PMID: 35083969 DOI: 10.7554/eLife.72801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Al-Ali D, Ahmed A, Shafiq A, McVeigh C, Chaari A, Zakaria D, Bendriss G. Fecal microbiota transplants: A review of emerging clinical data on applications, efficacy, and risks (2015-2020). Qatar Med J 2021;2021:5. [PMID: 34604008 DOI: 10.5339/qmj.2021.5] [Reference Citation Analysis]
19 Panpetch W, Phuengmaung P, Cheibchalard T, Somboonna N, Leelahavanichkul A, Tumwasorn S. Lacticaseibacillus casei Strain T21 Attenuates Clostridioides difficile Infection in a Murine Model Through Reduction of Inflammation and Gut Dysbiosis With Decreased Toxin Lethality and Enhanced Mucin Production. Front Microbiol 2021;12:745299. [DOI: 10.3389/fmicb.2021.745299] [Reference Citation Analysis]